Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Efficacy and Safety of Endoscopic Modalities for Colorectal Cancer Screening in Inflammatory Bowel Disease: A Systematic Review and Network Meta-Analysis.
Sinopoulou V, Nigam GB, Gordon M, Ganeshan M, Tokonyai MR, Dolwani S, Iacucci M, Rutter M, Subramanian V, Wilson A; British Society of Gastroenterology Colorectal IBD Surveillance Guideline Development Group; East JE. Sinopoulou V, et al. Clin Gastroenterol Hepatol. 2024 Dec 13:S1542-3565(24)01073-5. doi: 10.1016/j.cgh.2024.11.008. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39675405 Free article.
Update from 2010 (standard operating procedure): protocol for the 2024 British Society of Gastroenterology Guidelines on colorectal surveillance in inflammatory bowel disease.
Gordon M, Nigam GB, Sinopoulou V, Al Bakir I, Bateman AC, Din S, Dolwani S, Dhar A, Faiz OD, Hayee B, Healey C, Lamb CA, Leedham S, Kabir M, Iacucci M, Hart A, Morris AJ, Novelli M, Raine T, Rutter M, Shepherd NA, Subramanian V, Trudgill NJ, Vance M, Wilson A, White L, Wakeman R, East JE. Gordon M, et al. Among authors: al bakir i. BMJ Open Gastroenterol. 2024 Nov 29;11(1):e001541. doi: 10.1136/bmjgast-2024-001541. BMJ Open Gastroenterol. 2024. PMID: 39615897 Free PMC article.
Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitis.
Al Bakir I, Curtius K, Cresswell GD, Grant HE, Nasreddin N, Smith K, Nowinski S, Guo Q, Belnoue-Davis HL, Fisher J, Clarke T, Kimberley C, Mossner M, Dunne PD, Loughrey MB, Speight A, East JE, Wright NA, Rodriguez-Justo M, Jansen M, Moorghen M, Baker AM, Leedham SJ, Hart AL, Graham TA. Al Bakir I, et al. medRxiv [Preprint]. 2024 Jul 8:2024.07.08.24309811. doi: 10.1101/2024.07.08.24309811. medRxiv. 2024. PMID: 39040198 Free PMC article. Preprint.
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Wijnands AM, Penning de Vries BBL, Lutgens MWMD, Bakhshi Z, Al Bakir I, Beaugerie L, Bernstein CN, Chang-Ho Choi R, Coelho-Prabhu N, Graham TA, Hart AL, Ten Hove JR, Itzkowitz SH, Kirchgesner J, Mooiweer E, Shaffer SR, Shah SC, Elias SG, Oldenburg B; Dutch Initiative on Crohn and Colitis (ICC). Wijnands AM, et al. Among authors: al bakir i. Clin Gastroenterol Hepatol. 2024 Aug;22(8):1697-1708. doi: 10.1016/j.cgh.2024.02.014. Epub 2024 Feb 29. Clin Gastroenterol Hepatol. 2024. PMID: 38431223 Free article.
Poor Diagnostic Reproducibility in the Identification of Nonconventional Dysplasia in Colitis Impacts the Application of Histologic Stratification Tools.
Nasreddin N, Jansen M, Loughrey MB, Wang LM, Koelzer VH, Rodriguez-Justo M, Novelli M, Fisher J, Brown MW, Al Bakir I, Hart AL, Dunne P, Graham TA, Leedham SJ. Nasreddin N, et al. Among authors: al bakir i. Mod Pathol. 2024 Mar;37(3):100419. doi: 10.1016/j.modpat.2023.100419. Epub 2023 Dec 27. Mod Pathol. 2024. PMID: 38158125 Free article.
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study.
Iacucci M, Bonovas S, Bazarova A, Cannatelli R, Ingram RJM, Labarile N, Nardone OM, Parigi TL, Piovani D, Siau K, Smith SCL, Zammarchi I, Ferraz JGP, Fiorino G, Kiesslich R, Panaccione R, Parra-Blanco A, Principi M, Tontini GE, Uraoka T, Ghosh S; OPTIC-IBD Study Group. Iacucci M, et al. Gastrointest Endosc. 2024 May;99(5):756-766.e4. doi: 10.1016/j.gie.2023.11.018. Epub 2023 Nov 21. Gastrointest Endosc. 2024. PMID: 37993058 Free article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
23 results